Objective: To determine association of anemia and red blood cell (RBC) transfusions with necrotizing enterocolitis (NEC) in preterm infants.
Introduction
Necrotizing enterocolitis (NEC) is a known complication of prematurity with high morbidity and mortality. About 7 to 13% of all very low birth weight (VLBW) infants admitted to Neonatal Intensive Care Units (NICU) develop NEC, with mortality ranging from 10 to 44%. [1] [2] [3] A variety of factors have been associated with the development of NEC including early initiation of enteral feedings, use of postnatal steroids, patent ductus arteriosus and indomethacin use, breast milk versus formula feeds, and presence of umbilical catheters. 4 All preterm infants develop physiologic anemia of prematurity and this is aggravated by iatrogenic blood loss, resulting in frequent red blood cell (RBC) transfusions. It has been proposed that anemia leads to compromise of the mesenteric blood flow causing intestinal hypoxia and mucosal injury. [5] [6] [7] [8] [9] Transfusion-related reperfusion injury endured by a hypoxemic gut has also been postulated to predispose anemic preterm infants to develop NEC. [10] [11] [12] [13] [14] [15] We conducted a retrospective case-control study for the purposes of characterizing the association of NEC with anemia of prematurity and RBC transfusions in preterm infants.
Methods
This is a retrospective case-control study of preterm infants, p32 weeks gestational age (GA), diagnosed with NEC stage 2a or greater admitted to level III NICUs at Baystate Children's Hospital and Tufts Medical Center between January 2000 and December 2008. All cases of NEC were identified by review of administrative codes during the study period. Each case had two GA ( ± 1 week) and birth date (±2 weeks) matched controls admitted to NICU during the study period. Infants with known chromosomal anomalies, congenital heart disease and spontaneous intestinal perforation were excluded from both cases and controls.
Maternal and infant characteristics known to be associated with NEC were recorded. Maternal characteristics included pregnancyinduced hypertension, chorioamnionitis as defined by the American College of Obstetrics and Gynecology, administration of antenatal steroids before delivery, premature prolonged rupture of membranes and abnormal end-diastolic placental flow as documented by prenatal ultrasound. Infant data included birth date; GA documented as completed weeks of gestation, confirmed by the first trimester ultrasound or maternal last menstrual period; birth weight; gender; mode of delivery and Apgar scores at 1 and 5 min. Case charts were reviewed to confirm a diagnosis of NEC stage 2a or greater as classified by modified Bell staging criteria. 16 Infants with free intra-peritoneal air without any other radiographic or histo-pathological evidence of NEC were classified as having spontaneous intestinal perforation and excluded from the study. NEC was classified as early NEC if onset was within first 21 18 and the use of volume expander or vasopressor therapy; patent ductus arteriosus and need for indomethacin therapy or surgical ligation; positive blood culture; breast milk or formula feedings; achievement of full feeds before onset; use of additives (human milk fortifier, powdered formula, oral sodium and potassium supplements), iron therapy, erythropoietin therapy, antacid therapy and use of postnatal steroids for chronic lung disease. Information about the lowest Hct, total number of transfusions administered during the NICU stay, and RBC transfusion for cases and controls 24, 48 and 96 h before day of diagnosis for the case were recorded. For the controls, the timing for 24, 48 and 96 h was determined using the day of diagnosis in the index case and then using this chronological age as the reference point. We used 24 and 48 h as well as 96 h as the cutoffs based on the assumption that this would be the critical time period for any impact from low Hct and/or transfusions.
We also determined clinical outcomes before hospital discharge, including short gut syndrome, cholestasis, chronic lung disease, retinopathy of prematurity, intaventricular hemorrhage, length of stay, death and discharge home as markers of the impact of NEC on neonatal outcomes. Chronic lung disease was identified from the Vermont Oxford Network database-based algorithm, which has been tested with actual hospital data and found to be more accurate than the oxygen at 36 weeks measure. 19 Intaventricular hemorrhage was graded as per Papile's classification. 20 Retinopathy of prematurity was diagnosed based on the ophthalmologic exam and classified using International Classification of Retinopathy of Prematurity criteria. 21 Baystate Medical Center and Tufts Medical Center Institutional Review Board approvals were obtained before conducting the study.
Statistical analysis
Continuous variables were examined with paired t-tests and categorical variables were tested with McNemar's test. Propensity scores were generated for RBC transfusion and Hct, and used in subsequent analyses as covariates (see Appendix 1 for a description of the development of the propensity scores). 22 The purpose of propensity scores was to reduce the number of covariates in the models, while reducing bias because of confounding effects. 23 Multiple conditional logistic regression models were then created using the variables that were significant at a P-value <0.05. Separate models were created for NEC and Hct; NEC and RBC transfusions and NEC with four levels of anemia (normal plus three levels of increasing severity). Combined models were created to assess Hct and RBC transfusion and any interaction between them. Subgroup analyses were also performed for early and late NEC.
Results
A total of 333 infants were included in the studyF111 cases and 222 matched controls. The incidence of NEC in all VLBW infants over the study period ranged from 1.7% to 6.6%, with annual variations. The NEC cases and controls had similar mean GA (cases 26.9 ± 2.5 weeks, controls 27.2 ± 2.3 weeks; P ¼ 0.21) and birth weight (cases 969±309 g; controls 1023±338 g, P ¼ 0.16). All the variables in Table 1 , except total number of transfusions, were collected before the onset of NEC in the index case. The characteristics reaching significance in univariate analysis were abnormal end-diastolic placental flow, hypotension with use of volume expanders and vasopressors; patent ductus arteriosus, indomethacin use and surgical ligation; presence of central line; positive blood culture; achievement of full enteral feeds and use of additives; antacid and iron therapy; total number of transfusions during NICU stay; lowest Hct; transfusion within 24, 48 and 96 h of onset in the case (Table 1) . Breast milk feeds approached significance; P ¼ 0.06. In the univariate analysis for all cases of NEC, cases had lower Hct and were more likely to be transfused within 24, 48 and 96 h of NEC onset than controls ( Table 2 ). The transfusion guidelines were adhered to with fairly good compliance, the commonest reasons cited for transfusion were increased oxygen requirement or events of apnea, bradycardia and desaturations. The infants were transfused either 10 or 15 ml kg -1 of packed red blood cells over a 3-to 4-h period.
In the multivariate models after controlling for other factors including a propensity-like score for Hct, each one point decrease in the nadir Hct was associated with a 10% increase in the odds of NEC (odds ratio (OR) ¼ 1.10, (95% confidence interval (CI) 1.02 to 1.18), P ¼ 0.01). The risk of NEC increased with lower Hct. (Figure 1 ). In the combined multivariate model Hct continued to be a significant risk factor after adjusting transfusion within 96 h for Hct (OR ¼ 1.08, (95% CI: 1.00 to 1.17), P ¼ 0.05).
Clinical characteristics of the VLBW infants, excluding Hct, did not discriminate propensity for RBC transfusion. In the multivariate model, adjusting for similar covariates including propensity for transfusion, the association between transfusion within 96 h and NEC was not significant (OR ¼ 2.13, (95% CI: 0.95 to 4.80), P ¼ 0.07). However, to test for a temporal association further analyses were performed for transfusions within 24 and 48 h. There was a strong association of transfusion within 24 h with NEC (OR ¼ 7.60, P ¼ 0.001). This association became less strong for transfusion within 48 h (OR ¼ 5.55, (95% CI: 1.98 to 15.59), P ¼ 0.001) and was absent at 96 h. This temporal relationship was seen for all and early but not late NEC. (Table 2 , Figure 2 ). This association holds true when transfusion is used as an ordinal variable in the multivariate models (OR ¼ 1.79, P ¼ 0.001). In the combined multivariate models adjusting transfusion for Hct, transfusion within 24 h continues to have highest association (OR ¼ 5.73, P ¼ 0.008), followed by 48 h (OR ¼ 5.21, P ¼ 0.002) and no association for within 96 h (OR ¼ 1.47, P ¼ 0.39) ( Table 3 ). There was no evidence of interaction between Hct and RBC transfusion.
Other factors associated with higher NEC risk in the combined multivariate model included hypotension (OR ¼ 2.42, (95% CI: 1.16 to 5.03), P ¼ 0.02) and presence of central lines (OR ¼ 7.06, (95% CI: 1.26 to 39.53), P ¼ 0.03) while abnormal end diastolic flow (OR ¼ 0.11, (95% CI: 0.03 to 0.41), P ¼ 0.001) and iron therapy (OR ¼ 0.34, (95% CI: 0.12 to 1.00), P ¼ 0.05) were associated with lower risk. In contrast to previous studies, 6 breast milk feedings did not appear to be protective (OR ¼ 2.35, (95% CI: 0.79 to 7.02), P ¼ 0.13).
Associated in-patient morbidities noted for NEC cases and control infants are shown in Table 4 . Not surprisingly, the infants post-NEC had poorer outcomes as noted by a higher incidence of cholestasis, short gut syndrome, any intaventricular hemorrhage, longer length of stay and higher mortality.
Discussion
NEC is a significant cause of morbidity and mortality in VLBW infants. Other than prematurity, no single predictive factor has been clearly identified. 24, 25 A multifactorial theory of disease onset is widely accepted with recent interest in the role that anemia and red cell transfusion have in the pathophysiological pathway leading to NEC. We have demonstrated that Hct within 96 h of NEC onset is an important risk factor. Separating the influences of Hct and RBC transfusion on NEC is complicated as multiple factors with significant interplay are involved. Severe anemia in VLBW infants is frequently accompanied with other co morbid conditions. Similarly, RBC transfusion is usually associated with other conditions and therapeutic interventions. Despite these complex interactions, present data support the conclusion that low Hct within 96 h of onset is an important risk factor for development of NEC. An important question that then arises is why did the cases have lower Hct? This could be due to a number of reasons such as greater phlebotomy losses, occult blood loss, increased hemolysis or relative erythropoetic failure of an immature hematopoeitic system. These questions may be answered by future prospective studies.
In our study, we have attempted to disentangle the influence of Hct and RBC transfusion on NEC using a case-control approach. As multiple factors are likely to be involved in the development of NEC, and because many of these factors are correlated with both anemia severity and the probability of transfusion, which are themselves highly correlated, separating these influences is difficult. Nevertheless, we found that, despite rigorous methods to adjust away confoundingFincluding the use of high-dimensional [26] [27] [28] Anemia may result in decreased oxygen-carrying capacity of the blood to levels less than the demands of the growing tissues, resulting in increased anaerobic metabolism and the production of bi-products such as lactic acid. 15 In addition, the basal intestinal vascular resistance changes rapidly from the fetal to early neonatal life as this fetal dormant organ becomes functional for enteral nutrition; anemia may impair this normal transition. 29, 30 These effects may predispose the preterm gut for endothelial and mucosal apoptosis, a hallmark of NEC. 15 It thus seems plausible that the physiological impact of anemia initiates a cascade of events leading to ischemic-hypoxemic mucosal gut injury predisposing VLBW infants to NEC. 
Relationship of NEC to anemia and RBC transfusion R Singh et al
Erythropoietin has been shown to be protective against NEC. [31] [32] [33] Erythropoietin and the binding of its receptor are known to cause a signaling cascade that activates anti-apoptotic genes, which may directly affect the onset of NEC. This protective effect may be augmented by prevention of anemia of prematurity. In our study, iron supplementation was associated with a lower risk of NEC, consistent with the hypothesis that prevention or treatment of anemia may be important in preventing or reducing the risk of NEC, although the significance of this finding should be interpreted cautiously given the number of variables included in our model.
The data in early onset NEC patients were similar to the group as a whole, but we did not find an association between Hct and late onset NEC in stable growing preterm infants. Although this may be due to inadequate power to detect effects in this subgroup, it could also be that late NEC represents a distinct pathophysiologic entity with its own set of risk factors. Older infants, for example, may tolerate anemia better because infants reach a physiological nadir at this stage. Also, because infants in the control group for late NEC are going through their physiological Hct nadir, the distinction between the cases and the controls becomes less apparent.
Mally et al. 12 reported a relationship between late-onset NEC in 17 stable, growing, premature neonates who were transfused electively for anemia of prematurity. In contrast, Bednarek et al. 34 reported that there was no significant difference in the incidence of NEC between high versus low transfuser NICUs. In addition, the Premature Infant in Need of Transfusion (PINT) trial did not show a difference in the incidence of NEC between the low versus high transfuser groups, however, there was a trend toward increased incidence of intestinal perforations. 35 There was poorer neurological outcome in the low transfusion group in the Iowa study, but the incidence of NEC was not noted. 36, 37 Christensen et al. 38 examined factors that may help predict the progression of NEC to Bell stage III NEC. They found that 38% of their patients had been transfused, but did not have a comparison group and did not correct for Hct.
Currently, there are no standard national guidelines for transfusions in NICUs. [39] [40] [41] Protocols may exist in individual units but there is no uniformity. 34 Most transfusion protocols are related to respiratory functioning of neonates. 16, 17 Recent trends have been toward conservative approach to transfusion by accepting lower Hct values. Recently reported concerns that red cell transfusions increase the risk of NEC may have further lowered the Hct threshold for transfusion. After correcting for anemia and other clinical characteristics, we found a temporal relationship between RBC transfusion and NEC onset. RBC transfusions within 24 and 48 h were highly associated with NEC, however, this association Relationship of NEC to anemia and RBC transfusion R Singh et al disappeared by 96 h after transfusion. We cannot determine from our data the basis for this time course. It is possible that whatever factors are responsible for the increase in NEC 24 and 48 h after transfusion have dissipated by 96 h resulting in a NEC rate similar to that of the anemic population as a whole. It is also possible that nonspecific prodromal signs of NEC may have prompted caregivers to transfuse anemic infants. Although the temporal association with RBC transfusion from our data suggest the need for a cautious approach to liberalizing transfusions, the association between anemia and NEC raises the opposing concernFthat withholding treatment of severe anemia may increase risk in this population. [42] [43] [44] An experimental trial testing conservative and aggressive transfusion guidelines may be necessary to address this question.
As expected, we found that infants with hypotension and central arterial and venous catheters are at higher risk of NEC. Studies have shown that breast milk feedings decrease the risk of NEC. 6, 45 In contrast to these studies, we were surprised to find that breast milk feeding did not affect the occurrence of NEC. The reasons for this could be that a high number of infants in both groups were fed breast milk. Additionally, the use of additives may have a role to play. This is supported by a recent study by Sullivan et al. 46 who demonstrated that the decreased risk of NEC seen with a human milk-based diet was diminished in infants fed human milk fortified with bovine milk-based products.
It is well known that enteral nutrition has a significant role in the development of NEC in the preterm infants. Most of the cases and controls in the study were already feeding at the timing of onset of NEC in the index cases. Feedings were not routinely held during transfusions. At present, there is controversy about feeding practices while transfusing. It is not clear whether feeds should be withheld during RBC transfusion and if so when and for how long. Krimmel et al. 47 looked at superior mesenteric artery blood flow changes in relation to transfusions. They demonstrated the inability of a preterm infant to increase both flow volume and velocity to the gut after a feed in the immediate post-transfusion phase. Their study and our data documenting temporal association with the transfusion, with greatest risk in the first 24 h of being transfused, suggests that feeding practices in relation to transfusion also need to be addressed in future prospective trials.
We were also surprised to find that our models suggested that infants born to mothers with abnormal placental flow are at a lower risk of NEC, when previous studies have found such infants to be at higher risk. 48, 49 This may be secondary to conservative feeding management of these infants with a known risk factor.
Although our study has the limitation of being a retrospective it is the largest study conducted to date to test the associations between NEC, anemia and RBC transfusions. We have tried to minimize the confounding effects of the multiple variables that have known associations with NEC by using propensity score adjustments.
We conclude that anemia is associated with increased risk of developing NEC in preterm infants and this risk increases as anemia worsens. Although the majority of RBC transfusions do not result in NEC, in a subset of at risk preterm infants, RBC transfusions may be associated with increased odds of NEC. This association appears to have a temporal relationship, even after controlling for 'transfusion propensity' within a multivariable model also including Hct and other important clinical factors. Prospective studies may help identify a critical level of Hct, which may trigger the onset of NEC, and evaluate the potential influence of transfusions on the development of NEC.
